Vaccine and Infectious Disease Division
Early detection of certain diseases, such as cervical cancer or HIV, is a fundamental strategy for decreasing disease risk. VIDD researchers have shown that identification of clinically relevant biomarkers for detection in combination with early treatment can significantly improve patient survival rates. Biomarkers can also be used to optimize treatment strategies, ensuring each patient is given the treatment most likely to be effective and that unnecessary and ineffective treatment is avoided. Wide-ranging faculty research interests include statistical analyses of clinical trials; identification and evaluation of biomarkers for disease diagnosis, risk, and treatment efficacy; and genetic analysis of disease associations or effects.